Australia Phenylketonuria Market Size & Outlook, 2026-2034

Australia Phenylketonuria Market Insights

Reed Intelligence analysis indicates that the Australia Phenylketonuria Market size, valued at USD 23.3 Million in 2025, is expected to expand to USD 39.29 Million by 2034.
The Australia market is forecasted to expand at a CAGR of 5.96% spanning 2026–2034.
Enzyme Replacement Therapy held the leading position among By Treatment Type segments in 2025, based on market size.
Gene Therapy is projected to post the fastest growth rate, sustaining its position as the most attractive By Treatment Type segment during the forecast horizon.

Other Key Findings

Australia contributed 1.77% to the global Phenylketonuria Market size in 2025.
By 2034, United States is forecasted to remain the largest global market for Phenylketonuria Market.
In Asia Pacific, China is projected to capture the leading share of market size by 2034.
Among Asia Pacific markets, China is expected to post the fastest growth, reaching USD 275.18 Million by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 23.3 Million
Market Size In 2034	USD 39.29 Million
Largest segment	Enzyme Replacement Therapy
Units	Revenue in USD Million
CAGR	5.96% (2026-2034)
Segmnetation Covered
By Treatment Type	Enzyme Replacement Therapy Gene Therapy Medication Dietary Therapy
By Diagnosis	Genetic Testing Biochemical Testing Newborn Screening
By End-User	Specialty Clinics Research Institutes Home Healthcare Hospitals
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Australia Phenylketonuria Market By Treatment Type 2026-2034 (USD Million)

By Treatment Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Enzyme Replacement Therapy	XX.x	XX.x	XX.x	9.46	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Gene Therapy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Medication	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Dietary Therapy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Australia Phenylketonuria Market By Diagnosis 2026-2034 (USD Million)

By Diagnosis	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Genetic Testing	XX.x	XX.x	XX.x	10.54	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Biochemical Testing	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Newborn Screening	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Australia Phenylketonuria Market By End-User 2026-2034 (USD Million)

By End-User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Specialty Clinics	XX.x	XX.x	XX.x	11.34	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research Institutes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Home Healthcare	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Hospitals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.